Those investors who are planning to make money in the penny stock market should subscribe to FREE Alerts by visiting: http://www.PennyStockPickReport.com
Pacific Capital Bancorp (NASDAQ:PCBC) surged 23.97% or $0.35 to close at $1.81 on huge volumes of over 3.29 million shares on no news. The stock hit an intraday high of $1.89 and an intraday low of $1.46.The stock opened with a small gap up but gained buying interest on huge volumes in later half of the day. Over the past six months the stock declined over 74% . Pacific Capital Bancorp (PCB) is a community bank holding company providing full service banking, including consumer and commercial lending, trust and investment advisory services, and other consumer and business banking products through its subsidiaries’ retail branches, commercial and wealth management centers, and other distribution channels to consumers and businesses primarily located in the central coast of California.
VeriChip Corporation (NASDAQ:CHIP) climbed 13.02% to $2.43 on huge volume of 5.22 million shares after the company and its development partner RECEPTORS LLC announced today that VeriChip has received an exclusive license to RECEPTORS' Patent No. 7,504,364 titled 'Methods of Making Arrays and Artificial Receptors' and Patent No. 7,469,076 'Sensors Employing Combinatorial Artificial Receptors,' to use in conjunction with VeriChip's Patent No. 7,125,382 entitled 'Embedded Bio-Sensor System,' to develop an in vivo glucose-sensing RFID microchip. VeriChip Corporation is engaged in development, marketing, and sale of radio frequency identification (RFID) systems used for the identification and protection of people in the healthcare market.
Labopharm Inc. (CAN) (NASDAQ:DDSS) was the top roaring stock of the day as it surged up 38.24% to $1.88 on a massive volume of 8.12 million shares after it announces that its trazodone api supplier has resolved outstanding manufacturing issues with the FDA.. Labopharm Inc. is an international specialty pharmaceutical company focused on improving existing drugs by incorporating its advanced controlled-release technologies. The Company develops products internally in order to enter into strategic alliances or licensing agreements with national or international pharmaceutical companies that have the necessary resources and distribution networks to market and sell its pharmaceutical products.
ABOUT PennyStockPickReport
www.pennystockpickreport.com is one of the leading stock web site that provides free stock alerts and tracks small cap penny stocks that could be on the brink of a massive breakout. If you wish to get your company featured on our website then please contact us at info @PennyStockPickReport
Penny Stock Pick Report is an independent electronic publication that provides information on selected publicly traded companies. Penny Stock Pick Report is not a registered investment advisor or broker-dealer. Penny Stock Pick Report affiliates, directors, officers, and employees may purchase and sell additional shares in any company which are mentioned above and may profit in the event those shares rise in value. Please do your research before you plan to invest in any of the stocks mentioned above.